Public filings / PCVX on Yahoo Finance (opens in a new tab)
PCVX: insider buying, 13F holders, analyst moves
Vaxcyte Inc
A summary of public filings about Vaxcyte Inc. For the latest insider history, price chart, analyst changes and activist filings, open the live lookup.
SEC Form 13F · Q2 2026
3 of our 100 managers hold PCVX
Combined reported value $1.01B; 2 sold out since Q1 2026.
Holders among our 100 managers: 3 in Q3 2023, 3 in Q2 2026.
| Manager | Value | % of portfolio | Change vs Q1 2026 |
|---|---|---|---|
| RA Capital | $667.0M | 5.80% | Unchanged |
| Deep Track Capital | $250.0M | 3.68% | Unchanged |
| Maverick Capital | $93.8M | 0.85% | Added |
Important information
Facts from public SEC filings, shown for information only. Not a recommendation. Not individualized investment advice. Gulfstream Capital and its clients may hold positions in securities shown.